검색
Home
National
All
Politics
Social Affairs
Foreign Affairs
Defense
North Korea
Diplomatic Circuit
K-Wellness
Business
All
Industry
Technology
Mobility
Economy
Market
Life&Culture
All
Culture
Travel
Food
Books
People
Arts & Design
Film
Television
Performance
Sports
All
Soccer
Baseball
Golf
More Sports
World
All
World News
World Business
Opinion
All
Editorial
Viewpoints
K-pop
한국어판
More +
Weekender
English Eye
Podcast
Interactive
PR newswire
Global insight
Send E-mail
Medipost obtains US patent related to cartilage defect treatment
Medipost (078160) has obtained a US patent related to cartilage defect treatment, it announced on June 29.
From
Send to
Close
Send
Link copied
10:51
Opposition leader faces sentencing hearing over allegedly suborning perjury this week
10:06
golden horse caption
09:41
Japan voices regret over S. Korea's non-attendance of Sado memorial
16:13
S. Korea not to attend Sado mine memorial: foreign ministry
16:01
Gyeongju blends old with new
16:01
[What to Play] Cozy songs to warm you up
16:01
[Weekender] Korea's traditional sauce culture gains global recognition
16:01
Toxins at 622 times legal limit found in kids' clothes from Chinese platforms
16:01
At Gwangcheonok, try North Korean-style sundae gukbap
16:01
Over 80,000 malicious calls made to Seoul call center since 2020
Medipost obtains US patent related to cartilage defect treatment
June 29, 2016 - 14:28
By 황유미
[DISCLOSURE]
Medipost
(078160) has obtained a US patent related to cartilage defect treatment, it announced on June 29.
황유미
Most Popular
1
Dongduk Women’s University halts coeducation talks
2
Defense ministry denies special treatment for BTS’ V amid phone use allegations
3
OpenAI in talks with Samsung to power AI features, report says
4
Russia sent 'anti-air' missiles to Pyongyang, Yoon's aide says
5
Two jailed for forcing disabled teens into prostitution
6
Trump picks ex-N. Korea policy official as his principal deputy national security adviser
